Sunscreen fact and fiction: What the science says
Somehow, the idea that we need to protect our skin from the sun has blurred in recent years — largely due to online misinformation. We asked dermatologists about the science on sunscreen products.
Welcome from the Chair of Dermatology
Welcome to the Department of Dermatology at the Stanford University School of Medicine!
Our Department's mission is sustained leadership in patient care, in À¶Ý®ÊÓƵ, and in training leaders of our specialty in an environment that fosters creativity and synergy.
Dermatology at Stanford has a rich and wonderful tradition of excellence, community and service. From its establishment as an independent Department under the leadership of Dr. Eugene Farber in 1959, Dermatology at Stanford has grown tremendously. After several years of stewardship by Dr. Paul Jacobs, Dr. Eugene Bauer, serving first as chair then as Dean of Stanford School of Medicine, brought the Department into the current era of Molecular Medicine, while greatly strengthening its clinical and scientific foundations. From 1995 to 2010, Dr. Alfred Lane energetically built on these strengths, recruiting and supporting the majority of the current faculty in the Department. Today, the Department encompasses over 200 faculty members, trainees and staff, delivering outstanding patient care at over 8 total sites, including Stanford's affiliated partner institutions and the new Stanford Medicine Outpatient Center in Redwood City. The Department's academic efforts presently contribute the largest number of published high impact discoveries of any Dermatology Department in the world.
Looking to the future, the mission of the Department will remain focused, as it has been for many years, on leadership in discovery, in patient care and in training leaders of our specialty in an environment that fosters creativity, excellence and synergy. Over the next five years, we look forward to further Departmental success, with special clinical care and À¶Ý®ÊÓƵ emphases on the three thematic foci of the Department:
- Cutaneous Malignancies, including Melanoma, Non-Melanoma Skin Cancers and Cutaneous Lymphoma
- Regenerative Medicine and Inherited Skin Diseases, including developing stem cell therapies for disorders such as Epidermolysis Bullosa; and
- Immune Skin Disorders, including the full range of Autoimmune Skin Diseases.
The support of our entire community of faculty, alumni, patients, and friends will be instrumental in providing the creativity and resources needed in this effort to support trainees, young faculty, patient care advances and innovative À¶Ý®ÊÓƵ.
Over the years, excellence, dedication, generosity, and leadership have been trademarks of the Stanford Dermatology community. This is reflected in the wonderful teaching contributions of our Adjunct Clinical Faculty, in the generous support of our alumni and friends, and in the phenomenally talented generations of young people emerging from the Department to help lead the field. In the months and years ahead, it is my hope you will continue to engage in the Department with your support and ideas. I am excited by the amazing opportunities to discover and apply new advances to the care of our patients in an environment that trains the next generation of leaders in Dermatology. I welcome your suggestions to enhance these endeavors and thank you for your efforts as part of the Stanford Dermatology community.
Respectfully,
Paul A. Khavari, M.D., Ph.D.
Carl J. Herzog Professor and Chairman